MedTrace Logo

Using Fluorescence Angiography to Detect Occult Shock

NCT02846727 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-01-11

No results posted yet for this study

Summary

The purpose of this study is to determine if fluorescence angiography can detect occult shock (hypoperfusion).

Conditions

  • Hypoperfusion

Interventions

DEVICE

skin perfusion image

Upon enrollment following written, informed consent, the patient will receive an injection of 7.5 mg of Indocyanine Green (ICG) intravenously (Dilute 25 mg of Indocyanine Green (ICG) with 10 cc of solvent to achieve a 2.5 mg/cc concentration.) Following injection, Novadaq's LUNA™ fluorescence angiography system will be utilized to map a standard skin perfusion image (SPI) over the upper extremities and anterior chest wall.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Kevin Pei, MD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-08-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02846727 on ClinicalTrials.gov